PH25183A - Controlling the growth of certain tumor tissue with chalcone derivatives - Google Patents

Controlling the growth of certain tumor tissue with chalcone derivatives

Info

Publication number
PH25183A
PH25183A PH36739A PH36739A PH25183A PH 25183 A PH25183 A PH 25183A PH 36739 A PH36739 A PH 36739A PH 36739 A PH36739 A PH 36739A PH 25183 A PH25183 A PH 25183A
Authority
PH
Philippines
Prior art keywords
growth
tumor tissue
controlling
chalcone derivatives
certain tumor
Prior art date
Application number
PH36739A
Other languages
English (en)
Inventor
Sai Prasad Sunkara
David M Stemerick
Michael L Edwards
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PH25183A publication Critical patent/PH25183A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH36739A 1987-04-09 1988-04-05 Controlling the growth of certain tumor tissue with chalcone derivatives PH25183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/036,227 US4904697A (en) 1987-04-09 1987-04-09 Controlling the growth of certain tumor tissue with chalcone derivatives

Publications (1)

Publication Number Publication Date
PH25183A true PH25183A (en) 1991-03-27

Family

ID=21887400

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36739A PH25183A (en) 1987-04-09 1988-04-05 Controlling the growth of certain tumor tissue with chalcone derivatives

Country Status (8)

Country Link
US (1) US4904697A (xx)
EP (1) EP0288794B1 (xx)
KR (1) KR880012217A (xx)
AT (1) ATE106723T1 (xx)
AU (1) AU599220B2 (xx)
DE (1) DE3889970T2 (xx)
PH (1) PH25183A (xx)
ZA (1) ZA882391B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753965A (en) * 1987-04-09 1988-06-28 Merrell Dow Pharmaceuticals, Inc. Method of treating multiple sclerosis with chalcone derivatives
AU634921B2 (en) * 1990-12-25 1993-03-04 Ohgen Research Laboratories Ltd. Deacetylcolchicine derivatives
AU2776892A (en) * 1991-10-07 1993-05-03 Cancer Immunology Research Corporation, The Treatment of premalignant and malignant lesions
US5681812A (en) * 1991-12-10 1997-10-28 Rush Presbyterian-St. Luke's Medical Center Methods and compositions for reducing multidrug resistance
WO1993011668A1 (en) * 1991-12-10 1993-06-24 Rush-Presbyterian-St. Luke's Medical Center Methods and compositions for reducing multi-drug resistance
US5952355A (en) * 1993-11-17 1999-09-14 Kyowa Hakko Kogyo Co., Ltd. Propenone derivatives
IL112205A0 (en) * 1994-01-06 1995-03-15 Res Dev Foundation Curcumin, analogues of curcumin and novel uses thereof
GB9401891D0 (en) 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US5834442A (en) * 1994-07-07 1998-11-10 Barbara Ann Karmanos Cancer Institute Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
EP0770601A4 (en) * 1995-05-10 1998-08-05 Kyowa Hakko Kogyo Kk PROPENONE DERIVATIVES
IL121789A (en) * 1996-10-03 2001-06-14 Rohm & Haas A medicinal product for inhibiting mammalian cell tumors
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
AU771994B2 (en) * 1996-12-02 2004-04-08 Ipxmedical, Llc Compositions and methods for treating or preventing inflammatory diseases
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
AU2004200715B2 (en) * 1996-12-02 2006-08-31 Angiotech International Ag Compositions and methods for treating or preventing inflammatory diseases
EP0947494A1 (en) * 1998-03-30 1999-10-06 F. Hoffmann-La Roche Ag Derivatives of phenoxy acetic acid and phenoxymethyltetrazole having antitumor activity
EP0947511A1 (en) * 1998-03-30 1999-10-06 F. Hoffmann-La Roche Ag Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
US6608101B1 (en) 2000-06-20 2003-08-19 Atherogenics, Inc. 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
US6545007B2 (en) 2000-11-17 2003-04-08 Idenix (Cayman) Limited Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines
FR2817749A1 (fr) * 2000-12-13 2002-06-14 Aventis Pharma Sa Nouvelle utilisation des composes de la classe des chalcones
GB0126889D0 (en) * 2001-11-08 2002-01-02 Paterson Inst For Cancer Res Compounds and their uses
PE20030758A1 (es) * 2001-12-05 2003-10-07 Aventis Pharma Sa 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
US20040147584A2 (en) * 2001-12-05 2004-07-29 Aventis Pharma S.A. 1,3-diarylprop-2-en-1-ones, compositions containing them and use thereof
FR2833008B1 (fr) * 2001-12-05 2004-05-21 Aventis Pharma Sa 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR2833004B1 (fr) * 2001-12-05 2004-12-10 Aventis Pharma Sa Aryl-cycloalcaines substitues, compositions les contenant et utilisation
WO2003053368A2 (en) * 2001-12-19 2003-07-03 Atherogenics, Inc. Chalcone derivatives and their use to treat diseases
WO2004032947A1 (en) * 2002-10-09 2004-04-22 Unibioscreen S.A. Extract with anti-tumor and anti-poisonous activity
WO2004056727A2 (en) * 2002-12-19 2004-07-08 Atherogenics, Inc. Process of making chalcone derivatives
US7326734B2 (en) * 2003-04-01 2008-02-05 The Regents Of The University Of California Treatment of bladder and urinary tract cancers
US20050249667A1 (en) * 2004-03-24 2005-11-10 Tuszynski Jack A Process for treating a biological organism
WO2006004903A2 (en) * 2004-06-28 2006-01-12 Atherogenics, Inc. 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
CA2986547C (en) 2014-09-29 2023-03-21 The Penn State Research Foundation A compound for anti-cancer therapy that acts by targeting gof mutant p53 and stimulates p73 to restore the p53 pathway signaling
US11746104B2 (en) 2019-06-13 2023-09-05 Qatar University Chalcone-based chemotherapeutic compound for triple negative breast cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL255071A (xx) * 1959-08-20
US3729313A (en) * 1971-12-06 1973-04-24 Minnesota Mining & Mfg Novel photosensitive systems comprising diaryliodonium compounds and their use
US3808006A (en) * 1971-12-06 1974-04-30 Minnesota Mining & Mfg Photosensitive material containing a diaryliodium compound, a sensitizer and a color former
DE2602419A1 (de) * 1976-01-23 1977-07-28 Basf Ag Photopolymerisierbare masse
JPS6026122B2 (ja) * 1977-01-20 1985-06-21 富士写真フイルム株式会社 光重合性組成物
US4162162A (en) * 1978-05-08 1979-07-24 E. I. Du Pont De Nemours And Company Derivatives of aryl ketones and p-dialkyl-aminoarylaldehydes as visible sensitizers of photopolymerizable compositions
JPS54152091A (en) * 1978-05-22 1979-11-29 Fuji Photo Film Co Ltd Photopolymerizable composition
US4279930A (en) * 1978-10-10 1981-07-21 The Upjohn Company Process for treating inflammation
NZ192641A (en) * 1979-01-26 1984-10-19 Hoffmann La Roche Substituted acetophenones and pharmaceutical compositions
DE3066406D1 (en) * 1979-09-13 1984-03-08 Wellcome Found Diaryl compounds and pharmaceutical formulations containing them
CA1168659A (fr) * 1980-08-06 1984-06-05 Gerard Lang Derives de dibenzoylmethane quaternaire, leur utilisation comme agent filtrant solaire et composition cosmetique les contenant
US4753965A (en) * 1987-04-09 1988-06-28 Merrell Dow Pharmaceuticals, Inc. Method of treating multiple sclerosis with chalcone derivatives

Also Published As

Publication number Publication date
AU1416488A (en) 1988-10-13
US4904697A (en) 1990-02-27
ATE106723T1 (de) 1994-06-15
DE3889970D1 (de) 1994-07-14
KR880012217A (ko) 1988-11-26
ZA882391B (en) 1988-09-23
EP0288794A2 (en) 1988-11-02
DE3889970T2 (de) 1994-10-06
EP0288794A3 (en) 1988-11-23
EP0288794B1 (en) 1994-06-08
AU599220B2 (en) 1990-07-12

Similar Documents

Publication Publication Date Title
PH25183A (en) Controlling the growth of certain tumor tissue with chalcone derivatives
AU1416688A (en) Method of treating multiple sclerosis with chalcone derivatives
AU574350B2 (en) Human nerve growth factor by recombinant technology
AU6998787A (en) Transglutaminase inhibitors
AU633274B2 (en) Method for controlling the growth of non-osseous non-cartilaginous solid connective tissue
ATE286125T1 (de) Regulation der genexpression von bcl-2
DE68922974D1 (de) Verwendung von Hydroxycarbonsäuren zur Stabilisation von Bisphenolen.
AU6142186A (en) Use of melatonin or related compounds for the treatment of psoriasis
ATE90568T1 (de) Verwendung von zink- oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen.
DE69313316D1 (de) Verwendung von Oxazopyrrolochinolinen und Pyrrolochinolonchinonen zur Herstellung von Produktionsbeschleunigern von Nervenwachstumsfaktoren g
DE59100964D1 (de) Verwendung von Zink-Calciumhydroxid, Lecithin und PAO zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen.
EP0295559A3 (en) Pharmaceutical composition for the treatment of tumors
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
AU1416588A (en) Methods of treating gout with chalcone derivatives
AU7999687A (en) Active compounds for preventing tumor metastases
AU3439889A (en) Improvements relating to the control of neoplastic tissue growth
IL89901A0 (en) Strobilurine derivatives
AU1496988A (en) Porcine growth hormone analogs
EP0635010A1 (en) NEW CARDIOPROTECTIVE AGENTS.
IE881077L (en) Controlling the growth of tumor tissue with chalcone¹derivatives
DE3478745D1 (en) 6h-dibenz (b,e)(1,4)oxathiepin compounds
AU580646B2 (en) 13``-alkyl-17``-(3-aceloxy-propyl)-gonane
ATA167589A (de) Verfahren zur wuchsregulierung von wiesengesellschaften
ATE69137T1 (de) Stabilisiertes gossyplure und verfahren zu dessen herstellung.